ELIXOPHYLLIN SR: THEOPHYLLINE CAPSULES.
The THEOPHYLLINE CAPSULES is a the manufacturer industrial component. Key specifications include features_provided: INDIVIDUALLY SEALED, primary_container_type: STRIP, therapeutic_equivalent: FOREST LABORATORIES,INC., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, capsule_primary_container_content_quantity: 1000.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-142-4748, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ANHYDROUS;100 INDIVIDUALLY SEALED CAPSULES;LONG ACTION METHOD:EXTENDED RELEASE;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A; |
| features_provided | INDIVIDUALLY SEALED |
| primary_container_type | STRIP |
| therapeutic_equivalent | FOREST LABORATORIES,INC. |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| capsule_primary_container_content_quantity | 1000.000 |
| NSN | 6505-01-142-4748 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| PRIMARY CONTAINER TYPE | STRIP |
| SPECIAL FEATURES | ANHYDROUS;100 INDIVIDUALLY SEALED CAPSULES;LONG ACTION METHOD:EXTENDED RELEASE;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A; |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.